Berry GenomicsLtd Balance Sheet Health
Financial Health criteria checks 4/6
Berry GenomicsLtd has a total shareholder equity of CN¥1.9B and total debt of CN¥147.1M, which brings its debt-to-equity ratio to 7.7%. Its total assets and total liabilities are CN¥2.9B and CN¥995.0M respectively.
Key information
7.7%
Debt to equity ratio
CN¥147.07m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥304.01m |
| Equity | CN¥1.91b |
| Total liabilities | CN¥995.04m |
| Total assets | CN¥2.90b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 000710's short term assets (CN¥1.5B) exceed its short term liabilities (CN¥955.3M).
Long Term Liabilities: 000710's short term assets (CN¥1.5B) exceed its long term liabilities (CN¥39.8M).
Debt to Equity History and Analysis
Debt Level: 000710 has more cash than its total debt.
Reducing Debt: 000710's debt to equity ratio has increased from 6.7% to 7.7% over the past 5 years.
Debt Coverage: 000710's debt is well covered by operating cash flow (88.6%).
Interest Coverage: Insufficient data to determine if 000710's interest payments on its debt are well covered by EBIT.